Korro Bio, Inc. (KRRO) Stock Forecast & Price Target
Korro Bio, Inc. · NASDAQ
$10.70+0.06 (+0.56%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering Korro Bio, Inc, 9 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $8.00 to $30.00 (about 3.8x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $19.33 sits 81% above the current $10.70. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 8 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.27 next quarter toward $-5.04 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Moderate Buy
Strong Buy00%
Buy982%
Hold218%
Sell00%
Strong Sell00%
Based on 11 analysts giving stock ratings to Korro Bio, Inc.
As of Jul, 9 of 11 firms rate KRRO a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
KRRO EPS & revenue forecast
EPS · NEXT QUARTER
$-1.27
Range $-1.81 – $-0.68 · 9 analysts · -34% YoY
Next period, 9 analysts expect Korro Bio, Inc. to earn $-1.27 a share (range $-1.81 – $-0.68), versus $-1.92 a year earlier. Full-year consensus is $-5.18, growing to $-5.04 the year after.
REVENUE · NEXT QUARTER
$166.7K
Range $0 – $1.5M · 9 analysts · -85% YoY
Revenue is expected to reach $166.7K (range $0 – $1.5M), -84.7% year-over-year. Full-year consensus is $500.0K, rising to $222.2K next year.
Top analysts covering Korro Bio, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KRRO.
#1
Keay Nakae
Chardan Capital · Rank #130
Buy
$15.00+40.2% to target
Overall win rate
41%
+ Follow
#2
Yigal Nochomovitz
Citigroup · Rank #131
Buy
$21.00+96.3% to target
Overall win rate
43%
+ Follow
#3
Yasmeen Rahimi
Piper Sandler · Rank #152
Buy
$30.00+180.4% to target
Overall win rate
34%
+ Follow
#4
Mitchell Kapoor
HC Wainwright & Co. · Rank #165
Buy
$15.00+40.2% to target
Overall win rate
34%
+ Follow
#5
Luca Issi
RBC Capital
Hold
$8.00-25.2% to target
Coverage
—
+ Follow
KRRO stock forecast FAQ
What is KRRO's average 12-month price target?+
The 9 analysts with a live target average $19.33 for Korro Bio, Inc. over the next 12 months, ranging from a $30.00 high to a $8.00 low.
Is KRRO stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 11 analyst ratings, 9 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for KRRO?+
The Street-high target is $30.00 (Piper Sandler), and the Street-low is $8.00 (RBC Capital). The average of all 9 active targets is $19.33.
How many Wall Street analysts cover KRRO?+
11 analysts have an active rating on Korro Bio, Inc., and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering KRRO?+
Among analysts who currently cover KRRO, Keay Nakae of Chardan Capital has the strongest overall Quantellect track record (Rank #130). Their current call is Buy with a $15.00 target.
What is Korro Bio, Inc.'s projected EPS for next quarter?+
The consensus estimate is $-1.27 per share (range $-1.81 – $-0.68) across 9 analysts. Full-year EPS is projected at $-5.18, rising to $-5.04 the following year.
How much revenue is Korro Bio, Inc. expected to report next quarter?+
Consensus revenue is $166.7K (range $0 – $1.5M). Full-year revenue is projected at $500.0K, growing to $222.2K next year.
Have analysts been upgrading or downgrading KRRO lately?+
As of Jul, 9 of 11 firms rate KRRO a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KRRO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
